Najem H, Pacheco S, Turunen J, Tripathi S, Steffens A, McCortney K
bioRxiv. 2025; .
PMID: 40027731
PMC: 11870576.
DOI: 10.1101/2025.02.14.638299.
Sun A, Fan S, Choi S
Cancer Med. 2025; 14(1):e70523.
PMID: 39764760
PMC: 11705464.
DOI: 10.1002/cam4.70523.
Ridnour L, Heinz W, Cheng R, Wink A, Kedei N, Pore M
Cancer Res Commun. 2024; 4(10):2766-2782.
PMID: 39356141
PMC: 11497117.
DOI: 10.1158/2767-9764.CRC-24-0235.
Chen J, Larsson L, Swarbrick A, Lundeberg J
Nat Rev Clin Oncol. 2024; 21(9):660-674.
PMID: 39043872
DOI: 10.1038/s41571-024-00926-7.
Ridnour L, Cheng R, Kedei N, Somasundaram V, Bhattacharyya D, Basudhar D
JCI Insight. 2024; 9(12).
PMID: 38912586
PMC: 11383366.
DOI: 10.1172/jci.insight.165356.
ARTseq-FISH reveals position-dependent differences in gene expression of micropatterned mESCs.
Hu X, van Sluijs B, Garcia-Blay O, Stepanov Y, Rietrae K, Huck W
Nat Commun. 2024; 15(1):3918.
PMID: 38724524
PMC: 11082235.
DOI: 10.1038/s41467-024-48107-5.
Spatial analysis of NOS2 and COX2 interaction with T-effector cells reveals immunosuppressive landscapes associated with poor outcome in ER- breast cancer patients.
Ridnour L, Cheng R, Heinz W, Pore M, Gonzalez A, Femino E
bioRxiv. 2024; .
PMID: 38187660
PMC: 10769421.
DOI: 10.1101/2023.12.21.572867.
NOS2 and COX2 Provide Key Spatial Targets that Determine Outcome in ER- Breast Cancer.
Ridnour L, Heinz W, Cheng R, Wink A, Kedei N, Pore M
bioRxiv. 2024; .
PMID: 38187532
PMC: 10769386.
DOI: 10.1101/2023.12.21.572859.
Multiomics technologies for comprehensive tumor microenvironment analysis in triple-negative breast cancer under neoadjuvant chemotherapy.
Wang G, Yao Y, Huang H, Zhou J, Ni C
Front Oncol. 2023; 13:1131259.
PMID: 37284197
PMC: 10239824.
DOI: 10.3389/fonc.2023.1131259.
Identification of calcium and integrin-binding protein 1 as a reprogrammed glucose metabolism mediator to restrict immune cell infiltration in the stromal compartment of pancreatic ductal adenocarcinoma.
Ma J, Song Y, Zhuang T, Yang H, Yang X, Zheng J
Front Immunol. 2023; 14:1158964.
PMID: 37187730
PMC: 10175692.
DOI: 10.3389/fimmu.2023.1158964.
Interferon-gamma is quintessential for NOS2 and COX2 expression in ER breast tumors that lead to poor outcome.
Cheng R, Ridnour L, Wink A, Gonzalez A, Femino E, Rittscher H
Cell Death Dis. 2023; 14(5):319.
PMID: 37169743
PMC: 10175544.
DOI: 10.1038/s41419-023-05834-9.
Methods for assessment of the tumour microenvironment and immune interactions in non-small cell lung cancer. A narrative review.
Rangamuwa K, Aloe C, Christie M, Asselin-Labat M, Batey D, Irving L
Front Oncol. 2023; 13:1129195.
PMID: 37143952
PMC: 10151669.
DOI: 10.3389/fonc.2023.1129195.
A Low-Cost Modular Imaging System for Rapid, Multiplexed Immunofluorescence Detection in Clinical Tissues.
Gu J, Jian H, Wei C, Shiu J, Ganesan A, Zhao W
Int J Mol Sci. 2023; 24(8).
PMID: 37108170
PMC: 10138925.
DOI: 10.3390/ijms24087008.
PD-1CD8 T Cells Proximal to PD-L1CD68 Macrophages Are Associated with Poor Prognosis in Pancreatic Ductal Adenocarcinoma Patients.
Yang X, Wang G, Song Y, Zhuang T, Li Y, Xie Y
Cancers (Basel). 2023; 15(5).
PMID: 36900182
PMC: 10000394.
DOI: 10.3390/cancers15051389.
Multiplex Immunofluorescence: A Powerful Tool in Cancer Immunotherapy.
Sheng W, Zhang C, Mohiuddin T, Al-Rawe M, Zeppernick F, Falcone F
Int J Mol Sci. 2023; 24(4).
PMID: 36834500
PMC: 9959383.
DOI: 10.3390/ijms24043086.
Spatial multi-omics analyses of the tumor immune microenvironment.
Hsieh W, Budiarto B, Wang Y, Lin C, Gwo M, So D
J Biomed Sci. 2022; 29(1):96.
PMID: 36376874
PMC: 9661775.
DOI: 10.1186/s12929-022-00879-y.
Next-Generation Pathology Using Multiplexed Immunohistochemistry: Mapping Tissue Architecture at Single-Cell Level.
Maria Bosisio F, Van Herck Y, Messiaen J, Bolognesi M, Marcelis L, Van Haele M
Front Oncol. 2022; 12:918900.
PMID: 35992810
PMC: 9389457.
DOI: 10.3389/fonc.2022.918900.
The Role of Pathology-Based Methods in Qualitative and Quantitative Approaches to Cancer Immunotherapy.
Kuczkiewicz-Siemion O, Sokol K, Puton B, Borkowska A, Szumera-Cieckiewicz A
Cancers (Basel). 2022; 14(15).
PMID: 35954496
PMC: 9367614.
DOI: 10.3390/cancers14153833.
Breaking the Immune Complexity of the Tumor Microenvironment Using Single-Cell Technologies.
Caligola S, De Sanctis F, Cane S, Ugel S
Front Genet. 2022; 13:867880.
PMID: 35651929
PMC: 9149246.
DOI: 10.3389/fgene.2022.867880.
A framework for multiplex imaging optimization and reproducible analysis.
Eng J, Bucher E, Hu Z, Zheng T, Gibbs S, Chin K
Commun Biol. 2022; 5(1):438.
PMID: 35545666
PMC: 9095647.
DOI: 10.1038/s42003-022-03368-y.